[Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1. Zhou Y, Ji Z, Yan W, Zhou Z, et al. Oncol Rep 2024;52:152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou Y, Ji Z, Yan W, Zhou Z, et al. [Retracted] Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1. Oncol Rep 2024;52:152.
PMID: 39301643